novo nordisk insulin - Search News

Novo Nordisk beats in Q4

Novo Nordisk AS (NVO) Q4 2024 Earnings Call Highlights: Robust Growth in Sales and Profit Amid ...

Novo Nordisk AS (NVO) reports a strong 26% increase in sales and operating profit, with significant growth in obesity care and strategic acquisitions enhancing future market supply.

Seeking Alpha · 1d

Novo Nordisk Q4 Earnings: Outperformance Suggests Stock Price Comeback Starts Today

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO stock from hold to buy.

Houston Chronicle · 1d

Novo Nordisk: Q4 Earnings Snapshot

The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 83 cents per share. The drugmaker posted revenue of $12.26 billion in the period. For the year, the company reported profit of $14.

Novo Nordisk says it's not immune to potential Trump tariffs

Business Insider · 1d

Novo Nordisk’s (NVO) CEO Is Not Worried About Government Price Negotiations

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its popular diabetes

Bloomberg on MSN · 1d

Novo Nordisk Is Prepared for Trump’s Tariff Threat, CEO Says

Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive said, as tensions simmer between Copenhagen and Washington.

Reuters · 1d

Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned

Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, its chief executive said on Wednesday, but it is confident its business is well-positioned.

Novo Nordisk cashes in on obesity and diabetes drugs

This Is Money on MSN · 1d

Novo Nordisk cashes in on obesity and diabetes drugs as profits swell

Novo Nordisk reported turnover from obesity treatments soared by 57 per cent to 65.1 billion Danish kroner last year, largely driven by strong demand in the United States.

The Financial Times · 1d

Obesity drug sales help Novo Nordisk beat expectations

Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations. The company on Wednesday reported that net sales increased by 26 per cent year on year in 2024 to DKr290bn ($40bn),

Barron's on MSN · 1d

Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from legally selling cheap knockoff versions.

10d

Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

10d

Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

22h

Novo Nordisk Outlook Provides Some Welcome Relief

The company's shares rose as investors breathed a sigh of relief on strong sales growth and guidance, despite ongoing ...

Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026

Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in ...

Novo Nordisk: Among The Best Opportunities Of The Moment (Rating Upgrade)

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

10don MSN

Attorney General secures $35 Novo Nordisk insulin for Minnesotans

The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.

Novo Nordisk Foundation Will Not Fill Funding Gaps

Novo’s record profit from obesity drugs has given the Foundation a war chest to fund its philanthropic grants, although ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results